All four of these inhibitors reduce the reabsorption of filtered glucose, decrease the renal threshold for glucose, and promote urinary glucose excretion. Studies show that SGLT-2 use in diabetic kidney transplant recipients resulted in a decrease in hemoglobin A1C. There were potential side effects including increased infection risk and fluctuating allograft function
Yu M, Moreno C, Hoagland KM, Dahly A, Ditter K, Mistry M, et al
If you are experiencing changes in sexual function while on GLP-1 therapy, schedule a consultation at our Lexington, Louisville, or London, KY location
Sermorelin Sermorelin, the synthetic version of naturally occurring growth hormone-releasing hormone (GHRH), has been gaining some attention as an alternative to weight loss injectables like Mounjaro and Wegovy